Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/2012
06/21/2012US20120157436 5,6,7,8-TETRAHYDRO[1,2,4]TRIAZOLO[4,3-a]PYRAZINE DERIVATIVES AS P2X7 MODULATORS
06/21/2012US20120157435 Antiviral Compounds
06/21/2012US20120157434 Antimicrobial heterocyclic compounds for treatment of bacterial infections
06/21/2012US20120157433 Heteroaryl Compounds as Kinase Inhibitors
06/21/2012US20120157432 Novel pyrrolidine derived beta 3 adrenergic receptor agonists
06/21/2012US20120157431 Pyrimidine Sulphonamide Derivatives as Chemokine Receptor Modulators
06/21/2012US20120157430 N-(1-(substituted-phenyl)ethyl)-9h-purin-6-amines as pi3k inhibitors
06/21/2012US20120157429 Compounds useful as inhibitors of janus kinases
06/21/2012US20120157428 Bromodomain inhibitors and uses thereof
06/21/2012US20120157427 Pyrazole aminopyrimidine derivatives as lrrk2 modulators
06/21/2012US20120157426 Mutant-selective egfr inhibitors and uses thereof
06/21/2012US20120157425 New compounds, pharmaceutical compositions and uses thereof
06/21/2012US20120157424 Treatment of menopause-associated symptoms
06/21/2012US20120157423 Pharmaceutical composition in the form of a gel or a solution based on dihydrotestosterone, process for preparing it and uses thereof
06/21/2012US20120157422 Marker
06/21/2012US20120157421 17Beta-Alkyl-17Alpha-oxy-estratrienes
06/21/2012US20120157420 Treatment and prevention of secondary injury after trauma or damage to the central nervous system
06/21/2012US20120157419 Methods and compositions for treating alzheimer's disease
06/21/2012US20120157418 2-Methylene-19-Nor-Vitamin D Analogs and Their Uses
06/21/2012US20120157417 Compounds for the selective treatment of the intestinal immuno-inflammatory component of the celiac disease
06/21/2012US20120157416 xylitol containing comestible product
06/21/2012US20120157415 New Crystalline Form of Pemirolast
06/21/2012US20120157414 Cannabinoid receptor antagonists-inverse agonists useful for treating metabolic disorders, including obesity and diabetes
06/21/2012US20120157413 Phosphorous derivatives as chemokine receptor modulators
06/21/2012US20120157412 Substituted Pyrimidinyl Oxime Kinase Inhibitors
06/21/2012US20120157411 2-amino-4-arylthiazole compounds as trpai antagonists
06/21/2012US20120157410 Compositions and treatments using pyridazine compounds and cholinesterase inhibitors
06/21/2012US20120157409 Appetite suppressant product and method
06/21/2012US20120157408 Mixture of hyaluronic acid for treating and preventing peptic ulcer and duodenal ulcer
06/21/2012US20120157407 Galactose-pronged polysaccharides in a formulation for antifibrotic therapies
06/21/2012US20120157406 Method of preventing diarrhoea
06/21/2012US20120157405 Methods and Compositions for the Treatment of "Burning Feet Syndrome"
06/21/2012US20120157404 Antiviral compounds
06/21/2012US20120157403 Bicyclic and tricyclic derivatives as thrombin receptor antagonists
06/21/2012US20120157402 Methods for treating brain tumors
06/21/2012US20120157401 Methods for treating neurofibromatosis
06/21/2012US20120157400 Methods for treating kaposi sarcoma
06/21/2012US20120157399 Bile acid recycling inhibitors for treatment of obesity and diabetes
06/21/2012US20120157398 Materials and methods for treating diseases caused by genetic disorders using aminoglycosides and derivatives thereof which exhibit low nephrotoxicity
06/21/2012US20120157397 Trimethylamine-containing compounds for diagnosis and prediction of disease
06/21/2012US20120157396 Pyrazinamide for immunostimulation and the treatment of leishmaniases
06/21/2012US20120157392 Epilepsy treatment employing ketogenic compounds which arrest apoptosis
06/21/2012US20120157386 Neprilysin inhibitors
06/21/2012US20120157383 Neprilysin inhibitors
06/21/2012US20120157378 Methods and Compositions for Predicting a Subject's Susceptibility To and Risk of Developing Type 2 Diabetes
06/21/2012US20120157373 Antimicrobial compounds having protective or therapeutic leaving groups
06/21/2012US20120157371 High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds
06/21/2012US20120156314 11 beta, 13-DIHYDROHELENALIN DERIVATIVES AND USES THEREOF AS BOMBESIN RECEPTOR SUBTYPE 3 AGNOISTS
06/21/2012US20120156312 Compositions for Inhibiting Growth of Cancer Stem Cells
06/21/2012US20120156305 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
06/21/2012US20120156301 Methods and Compositions for Treating and Preventing Symptoms of Hormonal Variations
06/21/2012US20120156296 Antioxidants in fish oil powder and tablets
06/21/2012US20120156294 Pharmaceutical Compositions of Selective Factor Xa Inhibitors for Oral Administration
06/21/2012US20120156292 Stable compositions of famotidine and ibuprofen
06/21/2012US20120156291 Stable compositions of famotidine and ibuprofen
06/21/2012US20120156290 Process for preparing oxymorphone, naltrexone, and buprenorphine
06/21/2012US20120156289 Biodegradable Osmotic Pump Implant For Drug Delivery
06/21/2012US20120156287 Use of Vitelline Protein B as a Microencapsulating Additive
06/21/2012US20120156286 Compositions and methods for increased delivery of coenzyme q10
06/21/2012US20120156285 Methods of treating hypertriglyceridemia
06/21/2012US20120156277 Abuse resistant drugs, method of use and method of making
06/21/2012US20120156264 Injectable depot formulation comprising crystals of iloperidone
06/21/2012US20120156263 Ursodeoxycholic Acid-Synthetic Hydrotalcite-Eudragit Hybrid, Pharmaceutical Composition Containing the Same and Method for Preparing the Same
06/21/2012US20120156261 Disintegrating particle composition and orally rapidly disintegrating tablet
06/21/2012US20120156260 Prodrugs Containing an Aromatic Amine Connected By an Amido Bond to a Linker
06/21/2012US20120156259 Biodegradable Polyethylene Glycol Based Water-Insoluble Hydrogels
06/21/2012US20120156255 Drug eluting patch for the treatment of localized tissue disease or defect
06/21/2012US20120156246 Reprogramming cancer cells
06/21/2012US20120156244 Nasal Compositions and Uses Thereof
06/21/2012US20120156228 Methods, Kits, and Compositions for Generating New Hair Follicles and Growing Hair
06/21/2012US20120156226 Marker Differentially Expressed in Cancer Stem Cells and Methods of Using Same
06/21/2012US20120156225 Method of therapy
06/21/2012US20120156221 Method and Pharmaceutical Composition for Use in the Treatment of Neurodegenerative Disorders
06/21/2012US20120156219 Nitrogen-containing heterocyclic compounds and medicinal use thereof
06/21/2012US20120156216 Methods and Compositions for Treatment of Tumor Metastasis
06/21/2012US20120156213 Method for treating th17 inflammatory disease through inhibition of vascular endothelial growth factor receptors and pharmaceutical composition therefor
06/21/2012US20120156212 Methods and compositions for treating neoplasia
06/21/2012US20120156211 Porphyromonas gingivalis polypeptides
06/21/2012US20120156208 Therapeutic uses of inhibitors of rtp801
06/21/2012US20120156200 Method of treating cancer
06/21/2012US20120156197 Combination therapy with mdm2 and efgr inhibitors
06/21/2012US20120156187 Methods and compositions for modulation of blood-neural barrier
06/21/2012US20120156185 Nutritional compositions comprising citrus fibers
06/21/2012US20120156183 Sorcs1-like agent for use in the treatment of insulin resistance and diseases related thereto
06/21/2012US20120156180 Compositions and methods for the treatment of krabbe and other neurodegenerative diseases
06/21/2012US20120156179 Method for inducing extended self-renewal of functionally differentiated somatic cells
06/21/2012US20120156176 Thermoresponsive, biodegradable, elastomeric material and uses therefor
06/21/2012US20120156169 Recombinant mycobacterium strain expressing a mycobacterial fap protein under the control of a promoter active under hypoxia and its application for cancer therapy
06/21/2012US20120156166 Inhibitors of flaviviridae viruses
06/21/2012US20120156164 In situ-forming hydrogel for tissue adhesives and biomedical use thereof
06/21/2012US20120156163 Methods of decreasing sebum production in the skin
06/21/2012US20120156161 Perhydrolase variant providing improved specific activity
06/21/2012US20120156160 Perhydrolase variant providing improved specific activity
06/21/2012US20120156138 Methods and Compositions for the Treatment of Medical Conditions Involving Cellular Reprogramming
06/21/2012US20120156137 Composition for treatment of atopic dermatitis comprising glucosamine and derivatives thereof and a method for treatment of atopic dermatitis using them
06/21/2012US20120156135 Particles with multiple functionalized surface domains
06/21/2012US20120156134 Compositions and methods for detecting or eliminating senescent cells to diagnose or treat disease
06/21/2012US20120156133 Non-radioactive phospholipid compounds, compositions, and methods of use
06/21/2012US20120156128 Controllable release composition and method for preparing same
06/21/2012US20120153519 Method of Making a Soft Gel Capsule Comprising CoQ-10 Solubilized in a Monoterpene
1 ... 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 1184 1185 1186 1187 1188 1189 1190 1191 1192 1193 1194 ... 7860